Article
The TGF-B1 and IL-10 gene polymorphisms are associated with risk of developing silent myocardial ischemia in the diabetic patients.
Immunology letters - 1 Jan 2000
Cruz Miguel, Fragoso José Manuel, Alvarez-León Edith, Escobedo-de-la-Peña Jorge, Valladares Adan, Juárez-Cedillo Teresa, Pérez-Méndez Oscar, Vargas-Alarcón Gilberto
Abstract excerpt
Silent myocardial ischemia (SMI) is a multifactorial and polygenic disorder that results from an excessive inflammatory response. Considering the prominent role of IL-10 and TGF-B1 as regulators of the inflammatory process and vascular physiology, the aim of the present study was to analyze whether IL-10 and TGF-B1 single nucleotide polymorphisms (SNPs) are associated with SMI. The IL-10-1082 A>G (rs1800896),...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
